tirzepatide osa for the Treatment of Obstructive Sleep Apnea and Obesity Clinical Impact of Tirzepatide on

Subtle changes at 23 weeks

While GLP-1s slow digestion, they do not typically interfere with the primary function of anticoagulants, though your healthcare provider may want to monitor your levels more closely during the first few weeks of treatment

Frequently Asked Questions Q: Ive been trying to lose weight without success

For those experiencing persistent side effects, alternative GLP-1 receptor agonists or other glucose-lowering therapies may be considered

Outcomes The efficacy outcomes were as described earlier and assessed as described previously for the STEP studies in the systematic review section of this report

Methods Study design and participants We performed a benefit-harm balance modelling, which will be updated as new evidence emerges